C

CEL-SCI Corp
AMEX:CVM

Watchlist Manager
CEL-SCI Corp
AMEX:CVM
Watchlist
Price: 5.9 USD -1.67%
Market Cap: 47.3m USD

Relative Value

There is not enough data to reliably calculate the relative value of CVM.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CVM Relative Value
Base Case
Not Available
C
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
7.9
Forward
540.6
vs History
vs Industry
Median 3Y
-9.6
Median 5Y
-16.3
Industry
23.7
Forward
-0.3
vs History
vs Industry
Median 3Y
-14.4
Median 5Y
-25.4
Industry
22
vs History
vs Industry
Median 3Y
-12.6
Median 5Y
-22.5
Industry
23.8
vs History
93
vs Industry
45
Median 3Y
22.5
Median 5Y
26.1
Industry
3.3
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
8.3
Forward
591.6
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
10.1
vs History
vs Industry
Median 3Y
-11.7
Median 5Y
-19.3
Industry
6.4
Forward
0.3
vs History
vs Industry
Median 3Y
-10.1
Median 5Y
-17.3
Industry
7
Forward
-1.3
vs History
vs Industry
Median 3Y
-14.7
Median 5Y
-25.7
Industry
8.3
vs History
vs Industry
Median 3Y
-14.6
Median 5Y
-25.2
Industry
6.5
vs History
95
vs Industry
55
Median 3Y
12.6
Median 5Y
22.3
Industry
5.7

Multiples Across Competitors

CVM Competitors Multiples
CEL-SCI Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
CEL-SCI Corp
AMEX:CVM
47.3m USD 0 -1.9 -2.5 -2.1
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 770 229.5 -160 504.9 -194 904.1 -192 680.1
US
Abbvie Inc
NYSE:ABBV
396.2B USD 6.7 169 16.4 23.2
US
Amgen Inc
NASDAQ:AMGN
176.3B USD 4.9 25.2 18.2 18.2
US
Gilead Sciences Inc
NASDAQ:GILD
147.9B USD 5.1 18.2 12.2 12.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.4B USD 9.9 31.4 23 24.1
US
Epizyme Inc
F:EPE
94.1B EUR 2 086.1 -532.3 -579.6 -564.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78.7B USD 5.5 17.2 16.4 18.6
AU
CSL Ltd
ASX:CSL
84B AUD 3.6 18.5 12.5 15.6
NL
argenx SE
XBRU:ARGX
44.9B EUR 14.7 34.5 59.4 61.1
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
51.9B USD 16.2 1 192.5 156.6 189.9
P/S Multiple
Revenue Growth P/S to Growth
US
C
CEL-SCI Corp
AMEX:CVM
Average P/S: 3 377 238.2
Not Available
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
33 770 229.5
N/A N/A
US
Abbvie Inc
NYSE:ABBV
6.7
9%
0.7
US
Amgen Inc
NASDAQ:AMGN
4.9
5%
1
US
Gilead Sciences Inc
NASDAQ:GILD
5.1
4%
1.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
9.9
10%
1
US
E
Epizyme Inc
F:EPE
2 086.1
N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
5.5
6%
0.9
AU
CSL Ltd
ASX:CSL
3.6
5%
0.7
NL
argenx SE
XBRU:ARGX
14.7
49%
0.3
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
16.2
46%
0.4
P/E Multiple
Earnings Growth PEG
US
C
CEL-SCI Corp
AMEX:CVM
Average P/E: 188.3
Negative Multiple: -1.9
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -160 504.9 N/A N/A
US
Abbvie Inc
NYSE:ABBV
169
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
25.2
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
18.2
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
31.4
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -532.3 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.2
9%
1.9
AU
CSL Ltd
ASX:CSL
18.5
11%
1.7
NL
argenx SE
XBRU:ARGX
34.5
40%
0.9
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
1 192.5
N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
C
CEL-SCI Corp
AMEX:CVM
Average EV/EBITDA: 39.3
Negative Multiple: -2.5
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 904.1 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.4
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
18.2
11%
1.7
US
Gilead Sciences Inc
NASDAQ:GILD
12.2
7%
1.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23
16%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -579.6 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.4
11%
1.5
AU
CSL Ltd
ASX:CSL
12.5
8%
1.6
NL
argenx SE
XBRU:ARGX
59.4
807%
0.1
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
156.6
N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
C
CEL-SCI Corp
AMEX:CVM
Average EV/EBIT: 45.4
Negative Multiple: -2.1
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -192 680.1 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.2
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
18.2
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12.2
12%
1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24.1
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -564.2 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.6
13%
1.4
AU
CSL Ltd
ASX:CSL
15.6
11%
1.4
NL
argenx SE
XBRU:ARGX
61.1
N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
189.9
N/A N/A